Methocarbamol
- PMID: 33351427
- Bookshelf ID: NBK565868
Methocarbamol
Excerpt
Classified as a skeletal muscle relaxant, methocarbamol is a helpful medication used to manage acute musculoskeletal pain. This activity focuses on the pivotal indications, mechanism of action, and contraindications of methocarbamol in the treatment mosaic for acute musculoskeletal pain. With a spotlight on considerations including adverse events, efficacy evidence, drug interactions, and monitoring imperatives, healthcare professionals are empowered to tailor treatment strategies adeptly. By discussing the pharmacology of methocarbamol, healthcare professionals are equipped to address patient needs with precision, underscoring the indispensable role of the interprofessional healthcare team in orchestrating methocarbamol therapy for pain alleviation in musculoskeletal domains.
Copyright © 2025, StatPearls Publishing LLC.
Conflict of interest statement
Sections
References
-
- LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet] National Institute of Diabetes and Digestive and Kidney Diseases; Bethesda (MD): 2017. Jan 30, Methocarbamol. - PubMed
-
- van Tulder MW, Touray T, Furlan AD, Solway S, Bouter LM, Cochrane Back Review Group Muscle relaxants for nonspecific low back pain: a systematic review within the framework of the cochrane collaboration. Spine (Phila Pa 1976) 2003 Sep 01;28(17):1978-92. - PubMed
-
- See S, Ginzburg R. Skeletal muscle relaxants. Pharmacotherapy. 2008 Feb;28(2):207-13. - PubMed
-
- O'DOHERTY DS, SHIELDS CD. Methocarbamol; new agent in treatment of neurological and neuromuscular diseases. J Am Med Assoc. 1958 May 10;167(2):160-3. - PubMed
-
- FORSYTH HF. Methocarbamol (robaxin) in orthopedic conditions; preliminary report of one hundred cases. J Am Med Assoc. 1958 May 10;167(2):163-8. - PubMed
Publication types
LinkOut - more resources
Full Text Sources